Síndrome Cardiorrenal

  1. Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival. Circulation. 2010;122:265-272. doi: 10.1161/CIRCULATIONAHA.109.933275. Acceso libre. Link:
  2. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. JACC. 2013;62(6):485-95.doi: 10.1016/j.jacc.2013.04.070. Acceso libre. Link:
  3. The kidney in heart failure: an Update. Eur Heart J. 2015;36(23):1437-44. doi: 10.1093/eurheartj/ehv010. Acceso libre. Link:
  4. Management of Cardio-Renal Syndrome and Diuretic Resistance. Curr Treat Options Cardiovasc Med. 2016;18(2):11. doi: 10.1007/s11936-015-0436-4. Link:
  5. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2019;139(16):e840-e878. doi: 10.1161/CIR.0000000000000664. Acceso libre. Link:
  6. The role of the kidney in acute and chronic heart failure. Heart Fail Rev. 2020;25(1):107-118. doi: 10.1007/s10741-019-09870-6. Link:
  7. Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020 ;22:584-603. doi: 10.1002/ejhf.1697. Link:
  8. Acute Kidney Function Declines in the Context of Decongestion in Acute Decompensated Heart Failure. JACC Heart Fail. 2020;8(7):537-547. doi: 10.1016/j.jchf.2020.03.009. Link:
  9. Altered Hemodynamics and End-Organ Damage in Heart Failure: Impact on the Lung and Kidney. 2020;142(10):998-1012. doi: 10.1161/CIRCULATIONAHA.119.045409. Link:

Resistencia al tratamiento diurético: detección y estrategias de tratamiento

  1. Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol. 2010;56:1527-34. Acceso libre. Link:
  2. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011; 364:797-805. Acceso libre. Link:
  3. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012; 367:2296-304. Acceso libre. Link:
  4. Hypertonic saline with furosemide for the treatment of acute congestive heart failure: A systematic review and meta-analysis. Int J Cardiol. 2014 May 1;173(2):139-45. doi: 10.1016/j.ijcard.2014.03.020. Link:
  5. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat Rev. Cardiol 2015; 12:184-92. Link:
  6. Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: A meta-analysis of the literature. Herz 2015;40:423-35. Link:
  7. Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review. Cardiorenal Med 2015 ;5:145-56. Acceso libre. Link:
  8. Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial JAMA Cardiol 2017. 1; 2:950-958. Link:
  9. Diuretic Treatment in Heart Failure. NEJM. 2017 Nov 16;377(20):1964-1975. doi: 10.1056/NEJMra1703100. Acceso libre. Link:
  10. Utility of Urine Biomarkers and Electrolytes for the Management of Heart Failure. Curr Heart Fail Rep. 2019;16(6):240-249. doi: 10.1007/s11897-019-00444-z. Link:
  11. Subcutaneous furosemide for the treatment of heart failure: a state-of-the art review. Heart Fail Rev 2019;24:309-313. Link:
  12. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance. Eur J Heart Fail 2019 ;21:1415-1422. Acceso libre. Link:
  13. The use of diuretics in heart failure with congestion. A position statement from the Heart Failure Association of the European Society of Cardiology. EJHF 2019; 21:137-155. Acceso libre. Link:
  14. Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment. Nat Rev Cardiol. 2020;17(10):641-655. doi: 10.1038/s41569-020-0379-7. Link:
  15. Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review. 2020;75(10):1178-1195. doi: 10.1016/j.jacc.2019.12.059. Acceso libre. Link:
  16. Real World Use of Hypertonic Saline in Refractory Acute Decompensated Heart Failure: A U.S. Center's Experience. JACC Heart Fail 2020;8(3):199-208. doi: 10.1016/j.jchf.2019.10.012. Acceso libre. Link:
  17. Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial. Clin Res Cardiol. 2020;109(4):417-425. doi: 10.1007/s00392-019-01521-y. Link:
  18. Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology. 2020 Acceso libre.
  19. Ambulatory intravenous treatment of decompensated heart failure: An effective, safe and cost-effective approach. REC Cardioclinics. DOI: 10.1016/j.rccl.2020.05.009. Link:
  20. Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial. JACC Heart Fail 2020 Mar;8(3):157-168. doi: 10.1016/j.jchf.2019.09.012. Link:
  21. The value of urinary sodium assessment in acute heart failure. EHJACC 2020. doi: Acceso libre. Link:
  22. Usefulness of natriuresis to predict in-hospital diuretic resistance. Am J Cardiovasc Dis. 2020; 10(4):350-355. eCollection 2020. Acceso libre. Link:

Colaborador del Grupo de Trabajo de Síndrome Cardiorrenal